Riskpilot← Back to searchSign inGet full accessONKOVIT AS
ASActiveOrg 914114829Berglivegen 40, 9017 TromsøGeneral medical practice activities · NACE 8621Est. 20141 employees
Revenue 2025
NOK 4,3M
+7% vs 2024
EBITDA margin
0.9%
+1152% vs 2024
Equity ratio
-509.1%
Financial strength
Net profit 2025
NOK -12K
+82% vs 2024
| Revenue | NOK 4,3M | +7% |
| EBITDA | NOK 37K | +1152% |
| Net profit | NOK -12K | +82% |
| Total assets | NOK 155K | +7% |
| Equity | NOK -791K | -2% |
| Employees | 1 | — |
Legal name
ONKOVIT AS
Org number
914114829
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
5. september 2014
Share capital
NOK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Å levere helsetjenester, relatert rådgivings- og opplæringsvirksomhet, hva som herved står i forbindelse samt relaterte forsknings- og utviklings aktiviteter (fou). Selskapet kan engasjere seg på eiersiden i andre foretak.
Address
Berglivegen 40, 9017 Tromsø
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 779 | 2 831 | 2 936 | 3 088 | 3 267 | 2 775 | 2 854 | 3 139 | 3 773 | 3 984 | 4 266 |
| Staff expenses | −1 892 | −2 083 | −2 183 | −2 041 | −1 952 | −1 665 | −1 874 | −1 958 | −2 960 | −2 893 | −2 997 |
| EBITDA | −784 | −7 | −226 | 76 | 343 | 82 | 51 | 137 | −193 | −4 | 37 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −2 | −7 | −18 | −16 | −11 | −0 |
| EBIT | −784 | −7 | −226 | 76 | 343 | 80 | 44 | 120 | −208 | −15 | 37 |
| Net financials | −0 | −31 | −35 | −36 | −44 | −41 | −38 | −43 | −46 | −53 | −49 |
| Profit before tax | −785 | −39 | −261 | 41 | 298 | 39 | 6 | 77 | −254 | −67 | −12 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −785 | −39 | −261 | 41 | 298 | 39 | 6 | 77 | −254 | −67 | −12 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 196 | 390 | 265 | 214 | 260 | 195 | 209 | 338 | 201 | 145 | 155 |
| Equity | −620 | −658 | −919 | −878 | −580 | −541 | −535 | −458 | −712 | −779 | −791 |
| Long-term debt | 0 | 243 | 166 | 89 | 13 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 816 | 805 | 1 017 | 1 003 | 826 | 735 | 744 | 795 | 913 | 924 | 946 |
| Total debt | 816 | 1 048 | 1 183 | 1 092 | 839 | 735 | 744 | 795 | 913 | 924 | 946 |
EBITDA margin
0.9%
This company
15.8%
Market median
-94% vs market
20152025
Equity ratio
-509.1%
This company
38.2%
Market median
-1433% vs market
20152025
Return on equity
-1193800.0%
This company
18.4%
Market median
-6488143% vs market
20152025
Net profit margin
-0.3%
This company
8.1%
Market median
-104% vs market
20152025
Asset turnover
27.46×
This company
1.12×
Market median
+2352% vs market
20152025
Debt / equity
1.20×
This company
0.62×
Market median
-94% vs market
20152025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RK Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2016 | — | — | |
| Chairman | 2016 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ONKOVIT AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rune Kåre Vittring | Chief Executive Officer | 0 companies |
| Siv Nilsen Vittring | Board of Directors | 0 companies |
| Are Vittring | Chairman | 0 companies |